Catheter Precision - VTAK Revenue Dynamics YoY (Last Twelve Months)

Brandmark of Catheter Precision Corporation (VTAK)

A stable staff of development engineers ensures the technical resilience of Catheter Precision (VTAK). Year-over-year sales growth (TTM) demonstrates the asset's dynamics, where the indicator is maintained at 218.10. Revenues are based on the supply of non-invasive mapping systems to cardiac centers. The expansion of Amigo robotic systems into the B2B segment aims for a systematic capture of market share in the field of arrhythmia treatment.

VTAK: Catheter Precision Inc Sales Growth YoY (Last Twelve Months) 11/23/2025 - 10/05/2026

Catheter Precision Inc (VTAK) - metric breakdowns and financial figures

Summary company analytics:VTAK Catheter Precision Corporation
Manufactured product of Catheter Precision, Inc.

Catheter Precision high-tech developments in cardiology rely on a unique staff of biomedical experts, which directly converts into market expansion. By analyzing year-over-year sales volatility over a rolling 12-month period, an investor filters out random revenue fluctuations to assess the sustainable pace of business scaling. A stable upward trend confirms the fundamental viability of the model, although a sharp spike in the curve signals a risk of correction should demand subside.